clinical 1,834 words KG: AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial
Contents

AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial

Knowledge Graph

Related Hypotheses (25)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.59
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.86
CYP46A1 Overexpression Gene Therapy
Score: 0.86
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.83
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76

Related Analyses (17)

Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Related Experiments (1)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40

Knowledge Graph (1 edges)

AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial references AADC

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)